In the News – Forbes – Tessier-Lavigne
Genentech Brain Trust Leaves With $217 Million For New Startup To Fight Alzheimer’s And Parkinson’s “Three former top researchers at Genentech, the legendary biotech that is now part of Roche Holding, have raised $217 million in venture capital to … More »
Source: The Rockefeller University Newswire - Category: Biomedical Science Authors: pubaff Tags: In the News Source Type: news
More News: Alzheimer's | Biomedical Science | Biotechnology | Brain | Neurology | Parkinson's Disease | Venture Capital